Congestive heart failure clinical assessment

Revision as of 16:23, 9 June 2009 by Swilliams (talk | contribs)
Jump to navigation Jump to search
Heart failure
ICD-10 I50.0
ICD-9 428.0
DiseasesDB 16209
MedlinePlus 000158
eMedicine med/3552 
MeSH D006333

WikiDoc Resources for Congestive heart failure clinical assessment

Articles

Most recent articles on Congestive heart failure clinical assessment

Most cited articles on Congestive heart failure clinical assessment

Review articles on Congestive heart failure clinical assessment

Articles on Congestive heart failure clinical assessment in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Congestive heart failure clinical assessment

Images of Congestive heart failure clinical assessment

Photos of Congestive heart failure clinical assessment

Podcasts & MP3s on Congestive heart failure clinical assessment

Videos on Congestive heart failure clinical assessment

Evidence Based Medicine

Cochrane Collaboration on Congestive heart failure clinical assessment

Bandolier on Congestive heart failure clinical assessment

TRIP on Congestive heart failure clinical assessment

Clinical Trials

Ongoing Trials on Congestive heart failure clinical assessment at Clinical Trials.gov

Trial results on Congestive heart failure clinical assessment

Clinical Trials on Congestive heart failure clinical assessment at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Congestive heart failure clinical assessment

NICE Guidance on Congestive heart failure clinical assessment

NHS PRODIGY Guidance

FDA on Congestive heart failure clinical assessment

CDC on Congestive heart failure clinical assessment

Books

Books on Congestive heart failure clinical assessment

News

Congestive heart failure clinical assessment in the news

Be alerted to news on Congestive heart failure clinical assessment

News trends on Congestive heart failure clinical assessment

Commentary

Blogs on Congestive heart failure clinical assessment

Definitions

Definitions of Congestive heart failure clinical assessment

Patient Resources / Community

Patient resources on Congestive heart failure clinical assessment

Discussion groups on Congestive heart failure clinical assessment

Patient Handouts on Congestive heart failure clinical assessment

Directions to Hospitals Treating Congestive heart failure clinical assessment

Risk calculators and risk factors for Congestive heart failure clinical assessment

Healthcare Provider Resources

Symptoms of Congestive heart failure clinical assessment

Causes & Risk Factors for Congestive heart failure clinical assessment

Diagnostic studies for Congestive heart failure clinical assessment

Treatment of Congestive heart failure clinical assessment

Continuing Medical Education (CME)

CME Programs on Congestive heart failure clinical assessment

International

Congestive heart failure clinical assessment en Espanol

Congestive heart failure clinical assessment en Francais

Business

Congestive heart failure clinical assessment in the Marketplace

Patents on Congestive heart failure clinical assessment

Experimental / Informatics

List of terms related to Congestive heart failure clinical assessment

Cardiology Network

Discuss Congestive heart failure clinical assessment further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Template:WikiDoc Cardiology News Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview of Clinical Assessment of Congestive Heart Failure

ACC / AHA Guidelines- Initial Clinical Assessment of Patients Presenting With HF (DO NOT EDIT) [1]

Class I

1. A thorough history and physical examination should be obtained/performed in patients presenting with HF to identify cardiac and noncardiac disorders or behaviors that might cause or accelerate the development or progression of HF. (Level of Evidence: C)

2. A careful history of current and past use of alcohol, illicit drugs, current or past standard or “alternative therapies,” and chemotherapy drugs should be obtained from patients presenting with HF. (Level of Evidence: C)

3. In patients presenting with HF, initial assessment should be made of the patient’s ability to perform routine and desired activities of daily living. (Level of Evidence: C)

4. Initial examination of patients presenting with HF should include assessment of the patient’s volume status, orthostatic blood pressure changes, measurement of weight and height, and calculation of body mass index. (Level of Evidence: C)

5. Initial laboratory evaluation of patients presenting with HF should include complete blood count, urinalysis, serum electrolytes (including calcium and magnesium), blood urea nitrogen, serum creatinine, fasting blood glucose (glycohemoglobin), lipid profile, liver function tests, and thyroid-stimulating hormone. (Level of Evidence: C)

6. Twelve-lead electrocardiogram and chest radiograph (PA and lateral) should be performed initially in all patients presenting with HF. (Level of Evidence: C)

7. Two-dimensional echocardiography with Doppler should be performed during initial evaluation of patients presenting with HF to assess LVEF, LV size, wall thickness, and valve function. Radionuclide ventriculography can be performed to assess LVEF and volumes. (Level of Evidence: C)

8. Coronary arteriography should be performed in patients presenting with HF who have angina or significant ischemia unless the patient is not eligible for revascularization of any kind. (Level of Evidence: B)

Class IIa

1. Coronary arteriography is reasonable for patients presenting with HF who have chest pain that may or may not be of cardiac origin who have not had evaluation of their coronary anatomy and who have no contraindications to coronary revascularization. (Level of Evidence: C)

2. Coronary arteriography is reasonable for patients presenting with HF who have known or suspected coronary artery disease but who do not have angina unless the patient is not eligible for revascularization of any kind. (Level of Evidence: C)

3. Noninvasive imaging to detect myocardial ischemia and viability is reasonable in patients presenting with HF who have known coronary artery disease and no angina unless the patient is not eligible for revascularization of any kind. (Level of Evidence: B)

4. Maximal exercise testing with or without measurement of respiratory gas exchange and/or blood oxygen saturation is reasonable in patients presenting with HF to help determine whether HF is the cause of exercise limitation when the contribution of HF is uncertain. (Level of Evidence: C)

5. Maximal exercise testing with measurement of respiratory gas exchange is reasonable to identify high-risk patients presenting with HF who are candidates for cardiac transplantation or other advanced treatments. (Level of Evidence: B)

6. Screening for hemochromatosis, sleep-disturbed breathing, or human immunodeficiency virus is reasonable in selected patients who present with HF. (Level of Evidence: C)

7. Diagnostic tests for rheumatologic diseases, amyloidosis, or pheochromocytoma are reasonable in patients presenting with HF in whom there is a clinical suspicion of these diseases. (Level of Evidence: C)

8. Endomyocardial biopsy can be useful in patients presenting with HF when a specific diagnosis is suspected that would influence therapy. (Level of Evidence: C)

9. Measurement of B-type natriuretic peptide (BNP) can be useful in the evaluation of patients presenting in the urgent care setting in whom the clinical diagnosis of HF is uncertain. (Level of Evidence: A)

See Also

References

  1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep 20; 112(12): e154-235. Epub 2005 Sep 13. PMID 16160202

Template:SIB


Template:WikiDoc Sources